Skip to main content
Top
Published in: Reactions Weekly 1/2024

01-03-2024 | Nilotinib | Case report

Tyrosine kinase inhibitors

Various toxicities

Published in: Reactions Weekly | Issue 1/2024

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Othman T, et al. Toxicities Associated with Tyrosine Kinase Inhibitor Maintenance Following Allogeneic Hematopoietic Cell Transplantation in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia. Blood 142 (Suppl. 1): 2873, Nov 2023. Available from: URL: https://dx.doi.org/10.1182/blood-2023-187460 [abstract] Othman T, et al. Toxicities Associated with Tyrosine Kinase Inhibitor Maintenance Following Allogeneic Hematopoietic Cell Transplantation in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia. Blood 142 (Suppl. 1): 2873, Nov 2023. Available from: URL: https://​dx.​doi.​org/​10.​1182/​blood-2023-187460 [abstract]
Metadata
Title
Tyrosine kinase inhibitors
Various toxicities
Publication date
01-03-2024
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2024
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-54301-8

Other articles of this Issue 1/2024

Reactions Weekly 1/2024 Go to the issue

Case report

Tivozanib

Case report

Nivolumab